Direct interaction between NHERF1 and Frizzled regulates Β-catenin signaling

Oncogene

Volumn 30, Issue 1, 2011, Pages 32-42

  Wheeler, D S ^a   Barrick, S R ^a   Grubisha, M J ^a   Brufsky, A M ^a,b   Friedman, P A ^a   Romero, G ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

beta catenin; breast cancer; EBP50; Frizzled; NHERF1; Wnt

Indexed keywords

BETA CATENIN; FRIZZLED PROTEIN; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEIN ZO1; WNT PROTEIN;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; MAMMARY GLAND; MOUSE; NONHUMAN; PATHOGENESIS; PDZ DOMAIN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; BETA CATENIN; BREAST NEOPLASMS; CELL PROLIFERATION; CRICETINAE; CRICETULUS; FEMALE; FRIZZLED RECEPTORS; HUMANS; MICE; MICE, KNOCKOUT; PHOSPHOPROTEINS; SIGNAL TRANSDUCTION; SODIUM-HYDROGEN ANTIPORTER;

MUS;

EID: 78650982536     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.389     Document Type: Article

References (32)

1. Ayyanan A, Civenni G, Ciarloni L, Morel C, Mueller N, Lefort K et al. (2006). Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism. Proc Natl Acad Sci USA 103: 3799-3804.
2. Bates IR, Hebert B, Luo Y, Liao J, Bachir AI, Kolin DL et al. (2006). Membrane lateral diffusion and capture of CFTR within transient confinement zones. Biophys J 91: 1046-1058.
3. Cardone RA, Bellizzi A, Busco G, Weinman EJ, Dell'Aquila ME, Casavola V et al. (2007). The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells. Mol Biol Cell 18: 1768-1780.
4. Chen W, ten Berge D, Brown J, Ahn S, Hu LA, Miller WE et al. (2003). Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4. Science 301: 1391-1394.
5. Dai JL, Wang L, Sahin AA, Broemeling LD, Schutte M, Pan Y. (2004). NHERF (Na+/H+ exchanger regulatory factor) gene mutations in human breast cancer. Oncogene 23: 8681-8687.
6. Dolled-Filhart M, McCabe A, Giltnane J, Cregger M, Camp RL, Rimm DL. (2006). Quantitative in situ analysis of beta-catenin expression in breast cancer shows decreased expression is associated with poor outcome. Cancer Res 66: 5487-5494.
7. Ediger TR, Kraus WL, Weinman EJ, Katzenellenbogen BS. (1999). Estrogen receptor regulation of the Na+/H+ exchange regulatory factor. Endocrinology 140: 2976-2982.
8. Ellis MJ, Gao F, Dehdashti F, Jeffe DB, Marcom PK, Carey LA et al. (2009). Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: a phase 2 randomized study. JAMA 302: 774-780.
9. Fantozzi A, Christofori G. (2006). Mouse models of breast cancer metastasis. Breast Cancer Res 8: 212.
10. Garrido JL, Wheeler D, Vega LL, Friedman PA, Romero G. (2009). Role of phospholipase D in parathyroid hormone type 1 receptor signaling and trafficking. Mol Endocrinol 23: 2048-2059.
11. Gillett C, Smith P, Gregory W, Richards M, Millis R, Peters G et al. (1996). Cyclin D1 and prognosis in human breast cancer. Int J Cancer 69: 92-99.
12. Karthikeyan S, Leung T, Birrane G, Webster G, Ladias JA. (2001). Crystal structure of the PDZ1 domain of human Na(+)/H(+) exchanger regulatory factor provides insights into the mechanism of carboxyl-terminal leucine recognition by class I PDZ domains. J Mol Biol 308: 963-973.
13. Koo TH, Lee JJ, Kim EM, Kim KW, Kim HD, Lee JH. (2002). Syntenin is overexpressed and promotes cell migration in metastatic human breast and gastric cancer cell lines. Oncogene 21: 4080-4088.
14. Kreimann EL, Morales FC, de Orbeta-Cruz J, Takahashi Y, Adams H, Liu TJ et al. (2007). Cortical stabilization of beta-catenin contributes to NHERF1/EBP50 tumor suppressor function. Oncogene 26: 5290-5299.
15. Laura RP, Ross S, Koeppen H, Lasky LA. (2002). MAGI-1: a widely expressed, alternatively spliced tight junction protein. Exp Cell Res 275: 155-170.
16. Lin SY, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y et al. (2000). Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA 97: 4262-4266.
17. Luyten A, Mortier E, Van Campenhout C, Taelman V, Degeest G, Wuytens G et al. (2008). The postsynaptic density 95/disc-large/ zona occludens protein syntenin directly interacts with frizzled 7 and supports noncanonical Wnt signaling. Mol Biol Cell 19: 1594-1604.
18. Mangia A, Chiriatti A, Bellizzi A, Malfettone A, Stea B, Zito FA et al. (2009). Biological role of NHERF1 protein expression in breast cancer. Histopathology 55: 600-608.
19. Pan Y, Wang L, Dai JL. (2006). Suppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1). Breast Cancer Res 8: R63.
20. Pan Y, Weinman EJ, Dai JL. (2008). Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells. Breast Cancer Res 10: R5.
21. Ryo A, Nakamura M, Wulf G, Liou YC, Lu KP. (2001). Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat Cell Biol 3: 793-801.
22. Song J, Bai J, Yang W, Gabrielson EW, Chan DW, Zhang Z. (2007). Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer. Histopathology 51: 40-53.
23. Songyang Z, Fanning AS, Fu C, Xu J, Marfatia SM, Chishti AH et al. (1997). Recognition of unique carboxyl-terminal motifs by distinct PDZ domains. Science 275: 73-77.
24. Stemmer-Rachamimov AO, Wiederhold T, Nielsen GP, James M, Pinney-Michalowski D, Roy JE et al. (2001). NHE-RF, a merlin-interacting protein, is primarily expressed in luminal epithelia, proliferative endometrium, and estrogen receptor-positive breast carcinomas. Am J Pathol 158: 57-62.
25. Tetsu O, McCormick F. (1999). Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422-426.
26. Umekita Y, Ohi Y, Sagara Y, Yoshida H. (2002). Overexpression of cyclinD1 predicts for poor prognosis in estrogen receptor-negative breast cancer patients. Int J Cancer 98: 415-418.
27. Wang B, Bisello A, Yang Y, Romero GG, Friedman PA. (2007). NHERF1 regulates parathyroid hormone receptor membrane retention without affecting recycling. J Biol Chem 282: 36214-36222.
28. Wawrzak D, Luyten A, Lambaerts K, Zimmermann P. (2009). Frizzled-PDZ scaffold interactions in the control of Wnt signaling. Adv Enzyme Regul 49: 98-106.
29. Weinman EJ, Hall RA, Friedman PA, Liu-Chen LY, Shenolikar S. (2006). The association. Annu Rev Physiol 68: 491-505.
30. Wheeler D, Sneddon WB, Wang B, Friedman PA, Romero G. (2007). NHERF-1 and the cytoskeleton regulate the traffic and membrane dynamics of G protein-coupled receptors. J Biol Chem 282: 25076-25087.
31. Yao R, Natsume Y, Noda T. (2004). MAGI-3 is involved in the regulation of the JNK signaling pathway as a scaffold protein for frizzled and Ltap. Oncogene 23: 6023-6030.
32. Yu A, Rual JF, Tamai K, Harada Y, Vidal M, He X et al. (2007). Association of Dishevelled with the clathrin AP-2 adaptor is required for Frizzled endocytosis and planar cell polarity signaling. Dev Cell 12: 129-141.